ORPHENADRINE CITRATE J Code: J2360
Injection, orphenadrine citrate, up to 60 mg
Q4 2026 Medicare Payment Limit for J2360, effective October 1, 2026: $6.274 per HCPCS billing unit, down 19.3% from $7.777. From CMS's final file.
Drug & Product Overview
About ORPHENADRINE CITRATE
Orphenadrine Citrate is a medication aligned to the HCPCS J Code: J2360 for billing, pricing, and reimbursement purposes in the United States. Classified under Muscle Relaxant, it is administered via the intramuscular or intravenous routes and manufactured by multiple companies.
According to CMS Drug Use Information: Orphenadrine is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment.
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
Based on publicly available CMS files. The list of NDCs below is not exhaustive.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 00641-6182-10 | Orphenadrine Citrate Injection | Hikma Pharmaceuticals USA Inc. | 10 | 30 MG |
| 00641-6182-25 | Orphenadrine citrate | Hikma Pharmaceuticals USA Inc. | 25 | 60 MG / 2 ML |
| 25021-0651-02 | Orphenadrine Citrate | Sagent Pharmaceuticals | 10 | 60 MG / 2 ML |
ORPHENADRINE CITRATE Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →Historical Graphing and Billing Calculator
Log in to calculate billing and reimbursement with live ASP, WAC & AWP pricing.
Login to use the calculator →ORPHENADRINE CITRATE CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular |
CMS has identified Orphenadrine Citrate (J2360) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →
ORPHENADRINE CITRATE Medically Unlikely Edits (MUE)
The most billing units of J2360 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 60 mg. The limit is different in the office and the hospital. Use the one for your setting.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
ORPHENADRINE CITRATE Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Orphenadrine Citrate billing and coding guide?
Are there any available Orphenadrine Citrate patient assistance programs?
Where can I find Orphenadrine Citrate prescribing information?
Where can I find Orphenadrine Citrate side effect information?
Does billing ORPHENADRINE CITRATE require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to ORPHENADRINE CITRATE.